Collaborative Management of Patients With Estrogen Receptor–Positive Breast Cancer

Cyclin-dependent kinase (CDK) inhibitors represent a new form of cytotoxic chemotherapy. Advanced practitioners can read this article to find out about the science behind CDK inhibition, when CDKs are indicated, how to monitor for and manage side effects, as well as when and how to dose adjust.

Detalles Bibliográficos
Autores principales: Schwartzberg, Lee S., Greene, Heather R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003757/
https://www.ncbi.nlm.nih.gov/pubmed/29928547

Ejemplares similares

Ejemplares similares